** Shares of Rua Bioscience RUA.NZ rise 7.7% to NZ$0.028, eyeing their strongest trading session since May 21, if gains sustain
** Medical cannabis firm reaches settlement with Australian peer Cann Group CAN.AX following legal proceedings initiated by Rua in February 2024
** Proceedings on damage claims for breach of contractual rights to exclusively sell Cann's products in Australia
** Cann shares rise as much as 7.1% to A$0.02 in early hours of trade
** Rua adds both cos have executed new supply agreements to support their respective operations in New Zealand and Australia
** More than 129,000 shares change hands, 1.9 times its 30-day avg volume
** Rua down 3.5% YTD, including current session's moves
(Reporting by Nikita Maria Jino in Bengaluru)
((Nikita.Jino@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.